NDT PlusPub Date : 2011-12-01Epub Date: 2011-09-14DOI: 10.1093/ndtplus/sfr110
Andreas Pikwer, Einar Vernersson, Anders Frid, Gunnar Sterner
{"title":"Extreme lactic acidosis type B associated with metformin treatment.","authors":"Andreas Pikwer, Einar Vernersson, Anders Frid, Gunnar Sterner","doi":"10.1093/ndtplus/sfr110","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr110","url":null,"abstract":"<p><p>The elimination of metformin is exclusively through the kidneys and elevated plasma concentrations can cause lactic acidosis. We report a case of severe lactic acidosis (pH 6.60) occuring with ostensibly normal therapeutic doses of metformin in the setting of acute renal failure. Continuous veno-venous haemodiafiltration decreased plasma metformin concentrations from 266 lmol/L at presentation to 68 lmol/L, 21 h later. The patient improved rapidly. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"399-401"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr110","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33313791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01Epub Date: 2011-08-24DOI: 10.1093/ndtplus/sfr101
G H Neild, Yuvaram N V Reddy, Yogesh N V Reddy, Deepika Lunawat, Georgi Abraham
{"title":"Successful management of angiomyolipoma of the left kidney.","authors":"G H Neild, Yuvaram N V Reddy, Yogesh N V Reddy, Deepika Lunawat, Georgi Abraham","doi":"10.1093/ndtplus/sfr101","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr101","url":null,"abstract":"A 57-year-old woman with a creatinine of 0.8 mg/dL and a normal urine analysis, was investigated with technetium-99m renogram and multidetector computerized tomography (MDCT) as a renal donor for her daughter. The glomerular filtration rate (GFR) was 100 mL/min with the left kidney 42 mL/min and right kidney 58 mL/ min. MDCT revealed a large lipomatous tumour on the renal cortex of the left lower pole with exophytic extension into the perirenal space measuring 7.3 3 5.2 cm (Figure 1). The arterial phase revealed dual arterial supply to the left kidney with the tumour being supplied by a branch from the lower renal artery (Figure 2a). The presence of fat [67 Hounsfield unit (HU)] with interposed soft tissue (42 HU), ectatic vessels and an aneurysm that measured 9 mm 3 8.9 mm with no direct arteriovenous shunting favoured the diagnosis of angiomyolipoma. Superselective catheterization of the feeding artery was performed and the neovascular vessels were embolized. Post-embolization MDCT revealed complete obliteration of the abnormal feeding artery and the aneurysmal lumen (Figure 2b). A week later, the GFR was 107 mL/min, left kidney 43 mL/min and right kidney 64 mL/min. Angiomyolipoma is a benign renal neoplasm with variable amounts of fat, vascular and smooth muscle elements. Attenuation of less than 20 HU on computerized tomography is widely accepted to confirm the presence of fat and this finding confirms the diagnosis of angiomyolipoma [1]. A tumour >4 cm with an aneurysm measuring >5 mm has a high risk of rupture [2].","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"449-50"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr143
Sujoy Khan
{"title":"The role of hypoxia-inducible factor-1 alpha in TEMPI syndrome.","authors":"Sujoy Khan","doi":"10.1093/ndtplus/sfr143","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr143","url":null,"abstract":"Sir, \u0000 \u0000Two recent reports in The New England Journal of Medicine on a newly described syndrome, namely TEMPI syndrome (telangiectasia, erythrocytosis, monoclonal paraprotein, paranephric fluid collections, intrapulmonary shunting) are fascinating [1, 2], considering the number of cases where the radiological finding of perinephric fluid collections are not investigated further [3] or the concomitant laboratory finding of a paraprotein is dismissed as another case of monoclonal gammopathy of undetermined significance (MGUS). Sykes et al. [2] hypothesize that the IgG paraprotein in TEMPI syndrome may be pathogenic due to the resolution of most clinical features after a trial with the proteasome inhibitor, bortezomib. But, as bortezomib also affects the function of hypoxia-inducible factor-1 alpha (Hif-1α) and down-stream transcription of vascular endothelial growth factor (VEGF) [4], inhibition of Hif-1α would also explain the resolution of the symptoms seen in the patient described by Sykes et al. \u0000 \u0000Expression of Hif-1α and Hif-1α messenger RNA has been detected in all human tissues [5]. Intratumoral hypoxia is known to induce Hif-1α expression that increases VEGF and angiogenesis, but growth factors and loss-of-function mutations in von Hippel Lindau gene and p53 also induce Hif-1α expression (and possibly development of telangiectasias and erythrocytosis) [6]. Zhang et al. [7] showed that even under normoxic conditions, the oncogenic c-Myc/Hif-1α pathway modulates multiple myeloma cell production and mediates production and secretion of VEGF. Bortezomib was also shown to decrease both c-Myc and Hif-1α levels. Specific inhibitors of Hif-1α may therefore reverse most of the pathological manifestations of TEMPI syndrome.","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"454-5"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr143","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr130
Nina Brown, Anand Vardhan
{"title":"Developing an assisted automated peritoneal dialysis (aAPD) service-a single-centre experience.","authors":"Nina Brown, Anand Vardhan","doi":"10.1093/ndtplus/sfr130","DOIUrl":"10.1093/ndtplus/sfr130","url":null,"abstract":"<p><p>There is an ongoing increase in the number of elderly or frail patients requiring renal replacement therapy. Assisted automated peritoneal dialysis (aAPD) is one treatment option for this patient group and is becoming increasingly recognized as a distinct dialysis modality. In this article, we review the current status of aAPD and its evolution across Europe, describing the differences in service provision. We also report our experience locally of outcomes on our aAPD population over the last 4 years. We found that aAPD is a viable dialysis modality in the frail and elderly with limited lifespan, and complications of peritoneal dialysis are perhaps lower than would be expected in this population. This form of therapy also avoids the disruption to life which results from hospital-based dialysis. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 Suppl 3","pages":"iii16-iii18"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/13/sfr130.PMC4421462.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33161906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr147
Maria L Kafetzi, Aliki G Iniotaki, George C Liapis, Maria N Darema, Ilias I N Doxiadis, John N Boletis
{"title":"IgM antibodies towards pre-endothelial cells: strong indication for an association with accelerated rejection. A case report.","authors":"Maria L Kafetzi, Aliki G Iniotaki, George C Liapis, Maria N Darema, Ilias I N Doxiadis, John N Boletis","doi":"10.1093/ndtplus/sfr147","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr147","url":null,"abstract":"<p><p>A 27-year-old woman developed a graft loss due to an accelerated humoral rejection after receiving a blood group identical, human leucocyte antigens (HLA) haploidentical living-related kidney, despite the fact that she did not refer any sensitization event before transplantation. The complement-dependent cytotoxicity and flow cytometry crossmatches were negative for T and B cells. Retrospectively, IgM antibodies against donor precursor endothelial Tie-2(+) cells were detected using a commercially available assay and the pre-transplant serum sample. This case illustrates the necessity of detection of other than the classical HLA-directed antibodies prior organ grafting. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"416-7"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr147","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr152
Holly B Vince, Charles R Tomson, Eric J Loveday, Paul A Lear, John B Eastwood
{"title":"Nutcracker phenomenon presenting as loin pain haematuria syndrome.","authors":"Holly B Vince, Charles R Tomson, Eric J Loveday, Paul A Lear, John B Eastwood","doi":"10.1093/ndtplus/sfr152","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr152","url":null,"abstract":"<p><p>A 19-year-old female presented with bilateral severe loin pain associated with recurrent macroscopic haematuria. A provisional diagnosis of loin pain haematuria syndrome was made; the severity and frequency of pain led to referral to the pain management service. Alternative diagnoses were considered. Although previous reports of obstruction of the left renal vein have not described pain of this severity, magnetic resonance angiography was performed; it showed obstruction of the left renal vein as it passed between the superior mesenteric artery and aorta, i.e. the nutcracker phenomenon. Both pain and haematuria resolved fully after autotransplantation. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"418-20"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr152","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01Epub Date: 2011-07-25DOI: 10.1093/ndtplus/sfr088
Roshni Rathore, John Cheesbrough, Monika Pasztor, Alex Woywodt
{"title":"Sepsis and a painful shoulder in a haemodialysis patient.","authors":"Roshni Rathore, John Cheesbrough, Monika Pasztor, Alex Woywodt","doi":"10.1093/ndtplus/sfr088","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr088","url":null,"abstract":"Soft tissue infections are common in patients with end-stage renal failure, particularly those with concomitant diabetes and peripheral vascular disease. They usually affect the lower extremities and their microbiology is dominated by gram-positive organisms. Empirical antibiotic treatment is usually straightforward, and success or failure is heavily influenced by the degree of underlying vascular disease. We present an unusual case of treatment-resistant and eventually fatal soft tissue infection of the shoulder in a maintenance haemodialysis patient with known chronic lymphocytic leukaemia (CLL). We discuss the case with emphasis on the differential diagnosis of unusual soft tissue infections in a dialysis patient. We review possible causes of treatment failure, unusual organisms and implications for treatment.","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"439-42"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr132
Cormac Breen
{"title":"Anticoagulation and dialysis access practice in home haemodialysis in the UK.","authors":"Cormac Breen","doi":"10.1093/ndtplus/sfr132","DOIUrl":"10.1093/ndtplus/sfr132","url":null,"abstract":"<p><p>Anticoagulation is an important component of haemodialysis treatment in all settings. The therapeutic options available for anticoagulation of home haemodialysis are similar to those for haemodialysis in other settings. However, dialysis sessions with a wide range of treatment durations are undertaken at home, which can require different approaches to anticoagulation. Conference delegates were asked about the types of anticoagulation used in home dialysis and about surveillance strategies for monitoring vascular access, and the results are presented and discussed. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 Suppl 3","pages":"iii19-iii20"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/7c/sfr132.PMC4421460.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33161907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01DOI: 10.1093/ndtplus/sfr129
Martin Wilkie
{"title":"Home dialysis-an international perspective.","authors":"Martin Wilkie","doi":"10.1093/ndtplus/sfr129","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr129","url":null,"abstract":"<p><p>Background. There is strong evidence from a range of long-term conditions of improved outcomes where patients are involved in self-management. Against this background, the international trend for home dialysis continues to decline, with centre-based haemodialysis continuing its dominance. Methods. An opinion-based commentary exploring practice patterns and drivers for home dialysis internationally. Data are drawn from a number of sources including the 2010 United States Renal Data System report. Results. Drivers behind the use of home dialysis are complex including factors relating to the patient and their carers, health care team, health care system, geography and cultural factors. There are important examples where local champions or public health initiatives have had a positive impact on the use of home dialysis; however, in many settings significant barriers remain. Better systems for giving patient information, shared decision making and involving patients in their own care may have the potential to act as a driver for change. Conclusion. Centre-based haemodialysis continues to dominate renal replacement therapy internationally with notable exceptions. Such dominance suggests that most patients worldwide do not get much choice when it comes to modality selection. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 Suppl 3","pages":"iii4-iii6"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33161914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NDT PlusPub Date : 2011-12-01Epub Date: 2011-09-30DOI: 10.1093/ndtplus/sfr106
Guido R González-Fontal, Juan G Restrepo, Andrés F Henao-Martínez
{"title":"Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma.","authors":"Guido R González-Fontal, Juan G Restrepo, Andrés F Henao-Martínez","doi":"10.1093/ndtplus/sfr106","DOIUrl":"https://doi.org/10.1093/ndtplus/sfr106","url":null,"abstract":"<p><p>Minimal-change disease (MCD) is an exceptional paraneoplastic presentation. We are describing the case of an ovarian paraneoplastic nephrotic syndrome. The kidney biopsy was consistent with MCD. Steroids and immunosuppressive therapy were given with no change in the nephrotic-range proteinuria. A complete resolution of the nephrotic syndrome was soon observed with improvement of her clinical condition after five cycles of chemotherapy with paclitaxel and carboplatin and tumor-debulking surgery. Ovarian carcinoma paraneoplastic nephrotic syndrome secondary to MCD is an extremely rare event, which is important to recognize since it is responsive to the standard chemotherapy. </p>","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"4 6","pages":"427-9"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ndtplus/sfr106","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}